nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abstracts
|
|
|
2008 |
17 |
5 |
p. 450-459 |
artikel |
2 |
Abstracts
|
|
|
2008 |
17 |
5 |
p. 460-511 |
artikel |
3 |
Apoptosis in the pathogenesis of systemic lupus erythematosus
|
Munoz, LE |
|
2008 |
17 |
5 |
p. 371-375 |
artikel |
4 |
Atherosclerosis and systemic lupus erythematosus: the role of altered lipids and of autoantibodies
|
Hahn, BH |
|
2008 |
17 |
5 |
p. 368-370 |
artikel |
5 |
Authors Index
|
|
|
2008 |
17 |
5 |
p. 512-517 |
artikel |
6 |
Clinical trials in systemic lupus erythematosus (SLE): lessons from the past as we proceed to the future – the EULAR recommendations for the management of SLE and the use of end-points in clinical trials
|
Bertsias, G |
|
2008 |
17 |
5 |
p. 437-442 |
artikel |
7 |
Current treatment of lupus nephritis
|
Houssiau, FA |
|
2008 |
17 |
5 |
p. 426-430 |
artikel |
8 |
Lupus and pregnancy: ten questions and some answers
|
Ruiz-Irastorza, G |
|
2008 |
17 |
5 |
p. 416-420 |
artikel |
9 |
Lupus and the central nervous system
|
Huizinga, TWJ |
|
2008 |
17 |
5 |
p. 376-379 |
artikel |
10 |
Neuropsychiatric lupus and infectious triggers
|
Zandman-Goddard, G |
|
2008 |
17 |
5 |
p. 380-384 |
artikel |
11 |
New developments in lupus-associated antiphospholipid syndrome
|
Lockshin, MD |
|
2008 |
17 |
5 |
p. 443-446 |
artikel |
12 |
Pathogenesis of cutaneous lupus erythematosus
|
Kuhn, A |
|
2008 |
17 |
5 |
p. 389-393 |
artikel |
13 |
Pathogenic anti-nucleosome antibodies
|
Muller, S |
|
2008 |
17 |
5 |
p. 431-436 |
artikel |
14 |
Pathogenic role of antiphospholipid antibodies
|
Salmon, JE |
|
2008 |
17 |
5 |
p. 405-411 |
artikel |
15 |
Pathogenic role of auto-antibodies against complement components in systemic lupus erythematosus
|
Daha, MR |
|
2008 |
17 |
5 |
p. 385-388 |
artikel |
16 |
Preface
|
Kallenberg, CGM |
|
2008 |
17 |
5 |
p. 363-363 |
artikel |
17 |
Sex hormones and systemic lupus erythematosus
|
Petri, M |
|
2008 |
17 |
5 |
p. 412-415 |
artikel |
18 |
Systemic lupus erythematosus and cardiovascular disease
|
Frostegård, J |
|
2008 |
17 |
5 |
p. 364-367 |
artikel |
19 |
The innate immune system in SLE: type I interferons and dendritic cells
|
Rönnblom, L |
|
2008 |
17 |
5 |
p. 394-399 |
artikel |
20 |
The Janus of lupus – benefits and risks with B-cell therapy
|
van Vollenhoven, RF |
|
2008 |
17 |
5 |
p. 447-449 |
artikel |
21 |
Treating patients with lupus with B-cell depletion
|
Isenberg, DA |
|
2008 |
17 |
5 |
p. 400-404 |
artikel |
22 |
T-regulatory cells in systemic lupus erythematosus
|
La Cava, A |
|
2008 |
17 |
5 |
p. 421-425 |
artikel |